Blunted pathogen-associated molecular pattern motif induced TNF, IL-6 and IL-10 production from whole blood in dogs with lymphoma

Veterinary Immunology and Immunopathology

Volumn 144, Issue 1-2, 2011, Pages 167-171

  Fowler, Brooke L ^a   Axiak, Sandra M ^a   DeClue, Amy E ^a  

^a UNIVERSITY OF MISSOURI   (United States)

Author keywords

Canine; Cytokine; Infection; Inflammation; Neoplasia

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 6; LIPOTEICHOIC ACID; PEPTIDOGLYCAN; PHOSPHATE BUFFERED SALINE; TUMOR NECROSIS FACTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BACTERIUM; BLOOD; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOG DISEASE; FEMALE; LYMPHOMA; MALE; NEOPLASM; NONHUMAN; RISK ASSESSMENT; SEPSIS;

ANIMALS; BACTERIAL INFECTIONS; DOG DISEASES; DOGS; FEMALE; INTERLEUKIN-10; INTERLEUKIN-6; LEUKOCYTE COUNT; LYMPHOMA; MALE; TUMOR NECROSIS FACTOR-ALPHA;

BACTERIA (MICROORGANISMS); CANIS FAMILIARIS;

EID: 82555165015     PISSN: 01652427     EISSN: 18732534     Source Type: Journal    
DOI: 10.1016/j.vetimm.2011.07.011     Document Type: Article

References (35)

1. Baecklund E., Iliadou A., Askling J., Ekbom A., Backlin C., Granath F., Catrina A.I., Rosenquist R., Feltelius N., Sundstrom C., Klareskog L. Association of chronic inflammation, not its treatment, with increased lymphoma risk in rheumatoid arthritis. Arthritis Rheum. 2006, 54:692-701.
2. Baseggio L., Bienvenu J., Charlot C., Picollet J., Felman P., Coiffier B., Salles G. Higher LPS-stimulated TNF-alpha mRNA levels in peripheral blood mononuclear cells from non-Hodgkin's lymphoma patients. Exp. Hematol. 2001, 29:330-338.
3. Bergman P.J. Anticancer vaccines. Vet. Clin. N. Am. Small Anim. Pract. 2007, 37(6):1111-1119.
4. DeClue A.E., Cohn L.A., Lechner E.S., Bryan M.E., Dodam J.R. Effects of subanesthetic doses of ketamine on hemodynamic and immunologic variables in dogs with experimentally induced endotoxemia. Am. J. Vet. Res. 2008, 69:228-232.
5. Deitschel S.J., Kerl M.E., Chang C.H., DeClue A.E. Age-associated changes to pathogen-associated molecular pattern-induced inflammatory mediator production in dogs. J. Vet. Emerg. Critical Care (San Antonio) 2010, 20:494-502.
6. Faguet G.B., Davis H.C. Survival in Hodgkin's disease: the role of immunocompetence and other major risk factors. Blood 1982, 59:938-945.
7. Ferwerda B., McCall M.B., Verheijen K., Kullberg B.J., van der Ven A.J., Van der Meer J.W., Netea M.G. Functional consequences of toll-like receptor 4 polymorphisms. Mol. Med. 2008, 14:346-352.
8. Gadalla S.M., Rajan A., Pfeiffer R., Kristinsson S.Y., Bjorkholm M., Landgren O., Giaccone G. A population-based assessment of mortality and morbidity patterns among patients with thymoma. Int. J. Cancer 2010.
9. Hall M.W., Gavrilin M.A., Knatz N.L., Duncan M.D., Fernandez S.A., Wewers M.D. Monocyte mRNA phenotype and adverse outcomes from pediatric multiple organ dysfunction syndrome. Pediatr. Res. 2007, 62:597-603.
10. Hamoudi R.A., Appert A., Ye H., Ruskone-Fourmestraux A., Streubel B., Chott A., Raderer M., Gong L., Wlodarska I., De Wolf-Peeters C., MacLennan K.A., de Leval L., Isaacson P.G., Du M.Q. Differential expression of NF-kappaB target genes in MALT lymphoma with and without chromosome translocation: insights into molecular mechanism. Leukemia 2010, 24:1487-1497.
11. Hansen P.B., Al-Farra G. Treatment of central nervous system lymphoma following transplantation using monoclonal antibody and ganciclovir. Ugeskr. Laeger 2010, 172:2907-2908.
12. Heagy W., Hansen C., Nieman K., Cohen M., Richardson C., Rodriguez J.L., West M.A. Impaired ex vivo lipopolysaccharide-stimulated whole blood tumor necrosis factor production may identify septic intensive care unit patients. Shock 2000, 14:271-276. (discussion 276-277).
13. Heagy W., Nieman K., Hansen C., Cohen M., Danielson D., West M.A. Lower levels of whole blood LPS-stimulated cytokine release are associated with poorer clinical outcomes in surgical ICU patients. Surg. Infect. (Larchmt) 2003, 4:171-180.
14. Kaminska T., Hus I., Dmoszynska A., Kandefer-Szerszen M. Cytokine production in whole blood cell cultures of patients with B-lineage acute lymphoblastic leukemia. The influence of granulocyte-macrophage colony-stimulating factor. Arch. Immunol. Ther. Exp. (Warsz) 2001, 49:71-77.
15. Kaminska T., Hus I., Dmoszynska A., Kandefer-Szerszen M. Effect of granulocyte-macrophage colony-stimulating growth factor on interferon and tumor necrosis factor production in whole blood cell cultures of patients with acute myelogenous leukemia. Arch. Immunol. Ther. Exp. (Warsz) 2001, 49(Suppl 2):S83-S87.
16. Klastersky J., Paesmans M., Rubenstein E.B., Boyer M., Elting L., Feld R., Gallagher J., Herrstedt J., Rapoport B., Rolston K., Talcott J. The multinational association for supportive care in cancer risk index: a multinational scoring system for identifying low-risk febrile neutropenic cancer patients. J. Clin. Oncol. 2000, 18:3038-3051.
17. Kruger S., Schuster K., Feller A.C., Stutte H.J., Muller H. In vitro cytokine secretion and maturation phenotype of lymphoma-associated splenic macrophages. Pathol. Res. Pract. 1997, 193:511-518.
18. Landgren O., Engels E.A., Pfeiffer R.M., Gridley G., Mellemkjaer L., Olsen J.H., Kerstann K.F., Wheeler W., Hemminki K., Linet M.S., Goldin L.R. Autoimmunity and susceptibility to Hodgkin lymphoma: a population-based case-control study in Scandinavia. J. Natl. Cancer Inst. 2006, 98:1321-1330.
19. Le J., Vilcek J. Tumor necrosis factor and interleukin 1: cytokines with multiple overlapping biological activities. Lab. Invest. 1987, 56:234-248.
20. Le J.M., Vilcek J. Accessory function of human fibroblasts in mitogen-stimulated interferon-gamma production by T lymphocytes. Inhibition by interleukin 1 and tumor necrosis factor. J. Immunol. 1987, 139:3330-3337.
21. Majetschak M., Flach R., Kreuzfelder E., Jennissen V., Heukamp T., Neudeck F., Schmit-Neuerburg K.P., Obertacke U., Schade F.U. The extent of traumatic damage determines a graded depression of the endotoxin responsiveness of peripheral blood mononuclear cells from patients with blunt injuries. Crit. Care Med. 1999, 27:313-318.
22. Monneret G., Lepape A., Voirin N., Bohe J., Venet F., Debard A.L., Thizy H., Bienvenu J., Gueyffier F., Vanhems P. Persisting low monocyte human leukocyte antigen-DR expression predicts mortality in septic shock. Intensive Care Med. 2006, 32:1175-1183.
23. Muehlstedt S.G., Lyte M., Rodriguez J.L. Increased IL-10 production and HLA-DR suppression in the lungs of injured patients precede the development of nosocomial pneumonia. Shock 2002, 17:443-450.
24. Muenzer J.T., Davis C.G., Chang K., Schmidt R.E., Dunne W.M., Coopersmith C.M., Hotchkiss R.S. Characterization and modulation of the immunosuppressive phase of sepsis. Infect. Immun. 2010, 78:1582-1592.
25. Pronovost P., Needham D., Berenholtz S., Sinopoli D., Chu H., Cosgrove S., Sexton B., Hyzy R., Welsh R., Roth G., Bander J., Kepros J., Goeschel C. An intervention to decrease catheter-related bloodstream infections in the ICU. N. Engl. J. Med. 2006, 355:2725-2732.
26. Sekut L., Han B., Baer P., Verghese M.W., Silverstein R., Clifton L., Dennis S., Numerick M.J., Connolly K.M. A canine model for determination of the therapeutic index of cytokine inhibitors. Lab. Anim. Sci. 1995, 45:647-651.
27. Sorenmo K.U., Harwood L.P., King L.G., Drobatz K.J. Case-control study to evaluate risk factors for the development of sepsis (neutropenia and fever) in dogs receiving chemotherapy. J. Am. Vet. Med. Assoc. 2010, 236:650-656.
28. Stich A.N., DeClue A.E. Pathogen associated molecular pattern-induced TNF, IL-1beta, IL-6 and CXCL-8 production from feline whole blood culture. Res. Vet. Sci. 2011, 90:59-63.
29. Stryckmans P., Vandenplas B., Dorval C., Vandenbussche P., Massy M., Bernier M., Content J. Decreased production of IL-6 by peripheral blood mononuclear cells of patients with chronic lymphocytic leukemia and related disorders. Nouv. Rev. Fr. Hematol. 1988, 30:321-323.
30. Tamburini B.A., Phang T.L., Fosmire S.P., Scott M.C., Trapp S.C., Duckett M.M., Robinson S.R., Slansky J.E., Sharkey L.C., Cutter G.R., Wojcieszyn J.W., Bellgrau D., Gemmill R.M., Hunter L.E., Modiano J.F. Gene expression profiling identifies inflammation and angiogenesis as distinguishing features of canine hemangiosarcoma. BMC Cancer 2010, 10:619.
31. Tan A.M., Ferrante A., Goh D.H., Roberton D.M., Cripps A.W. Activation of the neutrophil bactericidal activity for nontypable Haemophilus influenzae by tumor necrosis factor and lymphotoxin. Pediatr. Res. 1995, 37:155-159.
32. Thurm, C.W., Halsey, J.F., 2005. Measurement of cytokine production using whole blood. Curr. Protoc. Immunol. 7, 18B (Chapter 7).
33. van der Poll T., Keogh C.V., Guirao X., Buurman W.A., Kopf M., Lowry S.F. Interleukin-6 gene-deficient mice show impaired defense against pneumococcal pneumonia. J. Infect. Dis. 1997, 176:439-444.
34. Wolska A., Lech-Maranda E., Robak T. Toll-like receptors and their role in hematologic malignancies. Curr. Mol. Med. 2009, 9:324-335.
35. Zhao M., Yang B., Wang J., Liu Y., Yu L., Jiang Y. Immunomodulatory and anticancer activities of flavonoids extracted from litchi (Litchi chinensis Sonn.) pericarp. Int. Immunopharmacol. 2007, 7:162-166.